The World Health Organization has backed clinical trials of two vaccine candidates designed for the Bundibugyo Ebola virus, for which no vaccine has been approved. The University of Oxford and the Serum Institute of India are developing one candidate, and Moderna the other; the DRC’s National Institute for Biomedical Research will lead the trial with international partners, including WHO. The outbreak has killed more than 5,300 people.
Reporting from 2 identified publishers across this event arc.
These publishers contributed reporting to the broader event history. Not every source addresses the specific development described above.
How this brief is built: The BriefBrief correlates multiple sources into one evolving event brief, updated as new facts emerge.
Page 6 of 21545
Same format. Every time.
Continue reading — sign in or create a free account with
